ABSTRACT
RESUMO
Dentre as hemopatias a púrpura trombocitopênica idiopática (PTI) se enquadra no grupo de doenças com alterações plaquetárias e se caracteriza pela diminuição no número de plaquetas do sangue. Clinicamente, crianças com PTI podem apresentar petéquias, equimose, hematúria, epistaxe e ocasionalmente hemorragias teciduais. As manifestações bucais, quando presentes, se caracterizam pelo sangramento gengival espontâneo e petéquias ou hematomas na mucosa, palato e língua. Portanto, é fundamental que o cirurgião-dentista tenha conhecimento sobre a patologia e terapêutica necessária e assim possa determinar o tratamento ideal para estes pacientes. O objetivo do trabalho é relatar o caso de um paciente de 4 anos de idade com PTI aguda, discutir as principais manifestações clínicas em crianças e orientar o cirurgião-dentista para o correto manejo destes pacientes.
Termos de indexação:
Hemoglobinopatia. Odontopediatria Purpura. Trombocitopênica. Platelets are small granular corpuscles measuring 2 to 4μ in diameter found in the bloodstream. Their role in the coagulation process is the production of a loose aggregate of platelets (temporary hemostatic plug) immediately after a lesion in the blood vessel. This plug is maintained and posteriorly converted into a definite fibrin clot 10 . Idiopathic Thrombocytopenic Purpura (ITP) is considered one of the most common disorders in children
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INTRODUCTION
Hemopathies are categorized in three large groups, according to the nature of the altered hematologic component. Thus, they are divided in disorders that affect erythrocytes (red blood cells), leucocytes (white blood cells) and hemorrhagic disorders, among which are included platelet and coagulation factors alterations 1 . Purpura is a disease included in the large group of hemorrhagic disorders and is distinguished by cutaneous hemorrhage and blood loss from mucous membranes and internal organs, which is always related to vascular or platelet alterations 2 . Thus thrombocytopenia, which is distinguished by the decrease in the number of blood platelets, is included in this large group 1,3-9. . with acute IPT. Complications are rare; however intracranial, subglottic, gastrointestinal and genital-urinary hemorrhage may occur 11 . Medical treatment for IPT patients adopts different intervening forms, according to individual conditions of each patient given that the immune system of each patient demands up-to-date therapeutics. Asymptomatic children or those whose illness is moderate without severe hemorrhagic episodes can be monitored and don't need specific medicinal therapy. In these cases follow-up without medication intervention is the best form of treatment and success of intermittent controls of platelet count until the disease remission 3, [17] [18] [19] . In more severe cases with risks of intracranial, gastro-intestinal and genitourinary hemorrhage, there is the option of platelet transfusion 3, 11, [18] [19] [20] . In cases of chronic IPT, in which no success was achieved with all the attempted therapeutic resources, splenectomy 3 is recommended, despite its performance restricted success 20 . In the case of acute IPT in children, there are treatment options with corticoids with high doses of intravenous immunoglobulin doses, and more recently with Anti-D immunoglobulin 18, [20] [21] . Mechanisms of action of corticoids employed in the treatment of acute IPT include the decrease of the antibody-platelet complex clearance and prevention of platelet phagocytosis. High doses of corticoids for a short period are used to increase platelets within 2 to 4 days. The dose ranges from 4mg/kg per day to 30mg/kg of prednisone or methyl prednisone for up to four days. No excessive collateral effects were observed for doses of 4mg/kg per day for four days [18] [19] . Another treatment option for acute IPT is intravenous immunoglobulins. The most utilized dose is of 0.8 to 1.0/kg/day for 1 or 2 days. In this dosage, it was observed an increase of platelet counts 24 hours after infusion. Collateral effects verified in the usage of intravenous immunoglobulin are headaches, body tremor, fever, nausea, vomit and aseptic meningitis 18 . Among the alternatives for the treatment of acute IPT, the anti-D immunoglobulin is the most recent option for children who were not submitted to splenectomy and whose erythrocytes are rhesus-positive. The Anti-D mechanism of action, in spite of its incomplete elucidation, acts on the reduction of platelet clearance [18] [19] . The dosage (50-75µg/kg) favors platelet increase within 24 to 48 hours after its administration. The collateral effects observed include headaches, body tremor, fever, nausea, vomiting (Bernard-Soulier Syndrome, Aldrich-Schlonlein Syndrome), vitamin C deficiency, viral infections (HIV, infectious mononucleosis), autoimmune disorders (systemic Lupus erythematosus), aplastic anemia, acute leukemia, and nonHodgkins lymphoma 4, [11] [12] [13] [14] [15] . In laboratorial exams, complete blood count shows severe decrease in platelet count bellow 20,000/ mm 3 in acute IPT and between 30,000/mm 3 up to 100,000/mm 3 in chronic IPT. In the coagulogram, bleeding time and coagulum retraction are possible alterations [6] [7] 11 . The number of white cells is normal and anemia may be present in some cases 11 . Currently, IPT is considered an autoimmune disease and its etiology is related to immunological mechanisms such as antibodies and antiplatelet immunoglobulin in the blood 16 . Genetic studies show the correlation of clinical development of IPT and certain genotypes, suggesting a genetic predisposition and modulation of the illness progression 15 . IPT is the result of the increment of the destruction of antiplatelet antibodies (autoantibodies) through cells of the reticuloendothelial system, especially the spleen 17 . The autoantibodies bind to platelets and are eliminated by the spleen, thus the disease severity reflects the balance of the capacity to produce platelets by the bone marrow mega-karyocyte and platelet destruction by the reticuloendothelial system.
IPT is categorized as acute and chronic; the latter is described based on the presence of thrombocytopenia for more than six months before the first signs and symptoms. Acute IPT prevails in children below 10 years old, affecting both genders. It is usually related to a viral infection history before the development of clinical signs with an interval of 2-21 days from the viral infection and the beginning of IPT 5, 10, 14 . There are reports that associate the illness to Epstein-Barr infection, varicella zoster infection and, particularly, after rubella vaccination 11 . Chronic IPT affects more teenagers than younger children, especially the female gender. There is a greater probability of patients affected by chronic IPT to develop autoimmune diseases, and 1/3 of these patients present laboratorial and clinical symptoms of collagen vascular disease 12 . Clinical signs of chronic IPT are milder and in some cases they can conceal and hamper the diagnosis 6 . IPT clinical symptoms include petechiae, ecchymoses, hematomas, epistasis, hematuria, mucinous cutaneous bleeding and occasionally tissual hemorrhage 1, [4] [5] [6] 11, 15 . In general, splenomegaly doesn't occur, and spleen is only palpable in 10% of the patients During anamnesis it was verified a history of viral infection before the development of IPT symptoms. In the physical exam, petechiae and hematomas were noticed around the knees (Figure 2 ) and on the forearm. According to the mother, these purple spots developed spontaneously and/or after minor wounds. and myalgia 18 . Hemolysis may occur and, consequently, temporary decrease of hemoglobin that in some cases develop hemoglobinemia and /or hemoglobinuria with renal insufficiency, anyhow, it is a rare occurrence [18] [19] [20] [21] . Despite its tendency to be a benign and self-limited condition, acute and chronic IPT are distinct diseases defined by age, platelet counts, bleeding symptoms and previous acute disease before the diagnosis 22 . Regarding buccal health, IPT can frequently bring about buccal mucosa alterations, among which petechiae, ecchymoses and hematomas in areas that are easily traumatized as buccal mucosa, tongue lateral edge and the limit between the hard palate and the soft palate 1, 4, 11 . Other IPT findings include spontaneous gingival bleeding, mucocutaneous bleeding 4, 15 and hemorrhagic vesicles 11 . This study objective is to provide guidance to the surgeon-dentist with regards to diagnose and attendance of children with Idiopathic Thrombocytopenic Purpura and a clinical case presentation.
CASE REPORT
The patient, 4 years old, was referred to the 
DISCUSSION
IPT is a common childhood disease with low morbidity and mortality, with or without hemorrhage 8 . Therefore, the surgeon-dentist knowledge with regards to potential alteration caused by this hemopathy is of great importance for dental treatment.
IPT typical signs observed in the patient, as petechiae and hematomas, coincide with the findings in the literature 1, 4, 11, 15 . However, the patient didn't present the usual symptoms of the disease, as the presence of petechiae, ecchymoses and hematomas on the tongue lateral border and on the limit between the hard palate and the soft palate 1, 4, 11 and, spontaneous gingival bleeding 4, 15 . Such clinical evidences show IPT attenuation, proven by laboratorial tests 6 . Medical treatment of patients with IPT assumes different intervention forms in accordance with the clinical conditions observed. Patients affected by IPT in the absence of severe hemorrhage are monitored and don't need specific medicinal therapy 3, [17] [18] [19] , a fact which was verified with this patient.
Regarding dental treatment of children affected by ITP, the clinical performance of the odontopediatrician must be based on previous knowledge of the evolution of the patient illness. Appropriate and comprehensive anamnesis is essential, given that sometimes the patients affected by this pathology don't show buccal clinical signs, as the patient herein described. Hence, the illness might not be noticed by the dentist, if the patient's history is not appropriately reported by their parents.
Dental procedures can be performed in patients with platelet counts above 50,000/mm 3 . In the need of surgical interventions on a patient whose platelet count is too low, blood transfusion or previous corticosteroid treatment is deemed necessary according to medical prescription 11 . The surgeon-dentist must avoid trauma to the buccal mucosa by carefully puncturing the needles, adapting orthodontic braces and avoiding super-activation 4 . Prescription of antiplatelet drugs, such as acetylsalicylic acid and ibuprofen, must be avoided.
Appropriate control of dental biofilm is of the utmost importance, in order to prevent gingival inflammation and infections. Individual protocols for prevention of caries must be established according to caries risk and age of each patient. If there is the need for restoration treatments, endodontic and surgical treatment, antibiotics prophylaxis can be performed to reduce the risk of postoperative infections 11 . The treatment of children with IPT must involve an interdisciplinary approach in which the odontopediatrician works together with the hematologist physician.
CONCLUSION
Hematological diseases present physical and buccal alterations that are considered important clinical signs for their diagnosis, as buccal mucosa alterations among which petechiae, ecchymoses and hematomas. Notwithstanding, these clinical signs are rare and the professional must be able to recognize Idiopathic Thrombocytopenic Purpura after a critical anamnesis aimed at providing guidance and effective treatment of the patients, as well as refer them to the physician.
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